How big is the Spasticity Market | Industry Trends & Forecast 2025

Code: MTA9183 Publication Date: Sep 2025

What is the size of Spasticity Market?

According to 6Wresearch internal database and industry insights, the Spasticity Market was valued at USD 11.2 Billion in 2024 and is expected to reach USD 18.9 Billion by 2031, growing at a CAGR of 7.3% during the 2025-2031.

The market is growing quickly as treatment methodologies are being pushed, the incidence of neurological disorders rises, the number of physiotherapy treatments increases, and the number of drug therapies increases daily. The increasing awareness level and ongoing rehabilitation programs support the positive growth of the spasticity market.

Growth Factors for Spasticity Market

  • Increased incidence of neurological disorders such as multiple sclerosis and cerebral palsy.
  • The development of new and advanced pharmacological treatments and muscle relaxants.
  • Increased presence of physiotherapy and rehabilitation programs to work with patients.
  • Advancements in assistive and mobility technologies, including the advancement of wearables.
  • Increased funding and investment into research related to targeted therapy for spasticity.

Spasticity Market Trends

The trends of the Spasticity Market show increased adoption of a multi-modal approach that depends on medication, physical therapy, and surgery. The rise of intrathecal baclofen therapy and botulinum toxin injections is on the rise, indicating better functionality and quality of life for patients.

Lastly, another trend in the Spasticity Market is the acceptance of digital health solutions used to monitor the patient's journey and delivery of care. The use of artificial intelligence-directed rehabilitation tools, telehealth treatment and assessment sessions, and wearable technology continues to expand access and develop tailored interventions.

Emerging Developments in the Spasticity Market

The Spasticity Market developments are centered on research in novel therapeutics, including gene therapy and regenerative medicine, aimed at targeting the root causes of spasticity. Such innovations are gaining momentum as clinical trials progress, offering promising long-term treatment pathways.

Additionally, the Spasticity Market is experiencing developments in surgical techniques, such as selective dorsal rhizotomy, alongside innovations in robotic-assisted rehabilitation devices. Pharmaceutical companies are expanding their portfolios with extended-release formulations and combination therapies to address unmet medical needs.

List of Leading Companies in the Spasticity Market

Some of the leading companies include:

  • Ipsen Biopharmaceuticals
  • Medtronic plc
  • Eli Lilly and Company
  • Merz Pharmaceuticals
  • Allergan plc
  • Novartis AG

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All